+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Diltiazem"

Calcium Channel Blockers - Global Strategic Business Report - Product Thumbnail Image

Calcium Channel Blockers - Global Strategic Business Report

  • Report
  • March 2025
  • 93 Pages
  • Global
From
Anti-Hypertensive Drugs Market Report 2025 - Product Thumbnail Image

Anti-Hypertensive Drugs Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Atherosclerosis Drugs Market Report 2025 - Product Thumbnail Image

Atherosclerosis Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Calcium Channel Blocker Market Report 2025 - Product Thumbnail Image

Calcium Channel Blocker Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
  • 13 Results (Page 1 of 1)
Loading Indicator

Diltiazem is a calcium channel blocker used to treat hypertension, angina, and certain types of arrhythmias. It is a commonly prescribed cardiovascular drug, and is available in both immediate-release and extended-release formulations. Diltiazem is also used to treat chronic stable angina, and is sometimes used in combination with other drugs to treat acute coronary syndrome. It is also used to treat atrial fibrillation and atrial flutter. Diltiazem is available in a variety of forms, including tablets, capsules, and injectable solutions. It is also available as a topical cream for the treatment of anal fissures. The drug is generally well tolerated, with few side effects. The diltiazem market is highly competitive, with many companies offering generic and branded versions of the drug. Some of the major players in the market include Pfizer, Novartis, Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more